Table 1.
Lipid content of Jurkat DRMs (mole%).a
| Lipid | DRM1
|
DRM2
|
||
|---|---|---|---|---|
| Control | Cdt-treated | Control | Cdt-treated | |
| SM | 10.5 ± 2.3 | 8.2 ± 1.2 | 11.8 ± 6.2 | 9.7 ± 5.3 |
| PC | 54.3 ± 4.0 | 53.8 ± 5.7 | 39.7 ± 10.7 | 42.5 ± 7.3 |
| PS | 7.7 ± 1.7 | 7.5 ± 2.5 | 11.0 ± 5.3 | 7.4 ± 0.5 |
| PI | 6.2 ± 0.6 | 5.2 ± 2.0 | 6.1 ± 2.1 | 4.0 ± 1.3 |
| PE | 20.8 ± 2.6 | 23.4 ± 1.3 | 22.8 ± 5.0 | 30.2 ± 13.2 |
| PG | 0.2 ± 0.3 | 0.2 ± 0.3 | ND | ND |
| Lyso-PG | 2.7 ± 0.2 | 1.6 ± 1.6 | 0.7 ± 0.1 | ND |
| PA | 5.0 ± 5.0 | 0.7 ± 0.7 | ND | ND |
a
Results are mean ± SEM of three experiments each performed in duplicate.
SM, sphingomyelin; PC, phosphatidylcholine; PS, phosphatidylserine; PI, phosphatidylinositol; PE, phosphatidylethanolamine; PG, phosphatidylglycerol; PA, phosphatidic acid; ND, not detected.